Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ESTA | STE |
|---|---|---|
| Price | $66.47 | $211.07 |
| Change today | ▲ 3.76% | ▲ 1.21% |
| Market cap | $1.98B | $20.58B |
| Return, 3 months | -27.0% | -1.7% |
| Return, year to date | -8.8% | -16.0% |
| Return, 1 year | +69.0% | -11.3% |
| P/E (TTM) | -52.3 | 25.8 |
| P/B | 91.7 | 2.9 |
| P/E percentile vs own 5y | 8th | 11th |
| Dividend yield | – | 1.19% |
| Revenue growth (YoY, latest qtr) | +27.1% | +7.3% |
| Net profit growth (YoY) | +39.6% | +12.9% |
| Gross margin | 69.3% | 44.4% |
| Operating margin | -18.5% | 18.9% |
| Net margin | -24.2% | 13.3% |
| Return on equity | – | 11.4% |
| Analyst target vs. price | +53.6% | +28.5% |
| Analyst buy share | 100% | 75% |
| RSI (14) | 42 | 43 |
| 30-day volatility | 39.5% | 15.6% |
| Max drawdown, 1 year | -34.1% | -25.4% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
